Neuromodulation as an Anti-inflammatory Treatment in SCI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neuromodulation as an Anti-inflammatory Treatment in SCI — Stella

Recruiting

Back to Spinal Cord Injuries trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Parkwood Institute, St Joseph's Health Care London, London, Ontario

Key details

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Enrollment target

~30 participants

Started

January 2024

Primary completion

August 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov